AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Auraglik-M80 Tablet

Prescription Icon
Prescription Required

Marketer

Aura Lifecare Private Limited

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Auraglik-M80 Tablet

Diabex Duo-80 tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This medication helps regulate blood glucose in diabetic patients. Diabex Duo-80 should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing risks of kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's one element of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Always carry a fast-acting glucose source (e.g., sugary snacks, juice) and maintain regular mealtimes. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Individuals with a history of heart disease should inform their physician prior to use. Consult your doctor before use if pregnant or breastfeeding. Regular blood glucose monitoring, along with blood tests for cell counts and liver function, may be recommended by your doctor.

Uses of Auraglik-M80 Tablet

Diabetes mellitus type 2

Major Benefits of Auraglik-M80 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Auraglik-M80 Tablet with a meal.

Common Side effects of Auraglik-M80 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Auraglik-M80 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Auraglik-M80 Tablets. Ingest each tablet whole; do not crush, chew, or break it before swallowing. Administer this medication with a meal.

How Auraglik-M80 Tablet works:

Gliclazide and metformin are combined in Auraglik-M80 tablets to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Auraglik-M80 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Auraglik-M80 tablets during pregnancy poses a confirmed risk to the fetus. While generally contraindicated, a physician might exceptionally prescribe it in emergencies where the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Auraglik-M80 Tablets while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Auraglik-M80 Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Auraglik-M80 Tablet use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Auraglik-M80 Tablets cautiously, potentially requiring dosage modification. Medical advice is essential. A low initial dose is typically prescribed for individuals with mild to moderate liver disease; however, Auraglik-M80 Tablets are contraindicated in those with severe hepatic dysfunction.

What if you forget to take Auraglik-M80 Tablet :

Should you forget a dose of Auraglik-M80 Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Auraglik-M80 Tablet

LabelValue
Potential for Dependence None.
Type of Medication Diabetes medication

FAQs on Auraglik-M80 Tablet

A combination tablet, Auraglik-M80, contains gliclazide and metformin, and is employed to manage type 2 diabetes mellitus in adults. Its efficacy in controlling blood sugar relies on adherence to a balanced diet and a regular exercise regimen. Gliclazide functions by stimulating insulin secretion from the pancreas, thereby reducing blood glucose. Metformin acts by decreasing hepatic glucose production and enhancing insulin responsiveness. This dual-drug formulation is unsuitable for treating type 1 diabetes.
Aruglik-M80 Tablet administration is linked to several frequently reported adverse events. These include low blood glucose (hypoglycemia), taste disturbances, queasiness, abdominal discomfort, loose stools, cephalalgia, and upper respiratory infections. Although infrequent, severe reactions such as lactic acidosis may occur. Prolonged therapy may additionally result in vitamin B12 insufficiency.
Aurglik-M80 Tablets may induce hypoglycemia, characterized by low blood sugar. Manifestations of low blood sugar can encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The likelihood of hypoglycemia increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Aurglik-M80 Tablet use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon adverse reaction to metformin. It's preventable by avoiding use in individuals with kidney impairment, the elderly, or those consuming substantial alcohol. Lactic acidosis symptoms can encompass muscular aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, and bradycardia. Should these symptoms arise, discontinue Auraglik-M80 Tablet immediately and seek medical attention.
Prolonged Auraglik-M80 Tablet use can indeed lead to vitamin B12 deficiency. This is because the medication hinders the stomach's absorption of vitamin B12. Untreated deficiency may result in anemia, neurological complications such as tingling and numbness in the extremities, weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate this risk, supplemental vitamin B12 intake, at a minimum, annually, has been proposed by some studies.
Patients with hypersensitivity to any constituent or inactive ingredient within Auraglik-M80 Tablet should not use this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Auraglik-M80 Tablet and alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Auralike-M80 tablets contain gliclazide and metformin, a dual-action formulation for managing type 2 diabetes. This medication helps regulate blood sugar in adult patients when combined with a balanced diet and consistent physical activity. Gliclazide functions by stimulating insulin secretion from the pancreas, while metformin reduces hepatic glucose output and enhances insulin responsiveness. This specific combination is unsuitable for patients with type 1 diabetes.
Aruglik-M80 Tablet may cause common adverse reactions such as low blood glucose, taste disturbances, nausea, abdominal discomfort, loose stools, headache, and upper respiratory infections. Rare but potentially severe side effects, including lactic acidosis, have also been reported. Prolonged treatment may result in vitamin B12 deficiency.
Auraglik-M80 Tablets can induce hypoglycemia, characterized by low blood sugar. Manifestations of low blood sugar may include nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Auraglik-M80 Tablet use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an infrequent adverse reaction to metformin. Risk factors include pre-existing kidney impairment, advanced age, and significant alcohol consumption. Lactic acidosis symptoms might encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Auraglik-M80 Tablet and seek immediate medical attention.
Prolonged Auraglik-M80 Tablet use can indeed lead to vitamin B12 deficiency. This is because the medication hinders the stomach's absorption of vitamin B12. Untreated deficiency may result in anemia, neurological complications such as tingling, numbness in extremities, muscle weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at a minimum of once annually, is recommended by some studies.
Individuals with hypersensitivity to any ingredient or inactive component of Auraglik-M80 Tablet should not use this medication. Similarly, its use is contraindicated in patients experiencing moderate to severe renal impairment or those with pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol while taking Auraglik-M80 Tablet is unsafe. This combination may reduce blood sugar to dangerously low levels (hypoglycemia) and heighten the risk of lactic acidosis.
Auraglik-M80 Tablet
92
MRP 112
17% off